Short Interest in Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Decreases By 18.5%

Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) was the recipient of a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling 37,500 shares, a decrease of 18.5% from the November 15th total of 46,000 shares. Based on an average daily trading volume, of 126,300 shares, the days-to-cover ratio is currently 0.3 days.

Tevogen Bio Price Performance

NASDAQ:TVGNW traded down $0.00 during trading hours on Monday, reaching $0.04. 45,800 shares of the company traded hands, compared to its average volume of 66,703. The firm’s 50-day moving average is $0.06 and its 200-day moving average is $0.03. Tevogen Bio has a 1-year low of $0.01 and a 1-year high of $0.28.

Tevogen Bio Company Profile

Tevogen Bio Holdings Inc operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients.